# NPIPB9

## Overview
The NPIPB9 gene encodes the nuclear pore complex interacting protein family member B9, a protein that is part of a family known for its interactions with the nuclear pore complex. This protein is involved in various cellular processes, including the regulation of nucleocytoplasmic transport, which is crucial for maintaining cellular homeostasis and function. The NPIPB9 protein is categorized as a nuclear pore complex-associated protein, playing a role in the transport of molecules between the nucleus and the cytoplasm. Research has highlighted its potential involvement in immune response modulation and metabolic regulation, as evidenced by its association with diseases such as juvenile idiopathic arthritis, Crohn's disease, and obesity (Li2023Immuneresponse; Mao2020Coding; Kim2024Largescale). The gene's expression and regulation are of significant interest due to their implications in various pathological conditions, making NPIPB9 a subject of ongoing biomedical research.

## Clinical Significance
The NPIPB9 gene has been implicated in several diseases and conditions through various studies. It has been identified as a novel susceptibility gene for juvenile idiopathic arthritis (JIA), suggesting its potential role in the disease's etiology (Kim2024Largescale). In the context of Crohn's disease, NPIPB9 has shown strong co-localization with the disease under Influenza A Virus (IAV) stimulation conditions, indicating a possible association with Crohn's disease susceptibility, particularly in response to specific immune stimuli (Li2023Immuneresponse). 

Additionally, NPIPB9 has been associated with obesity, where it was found to be downregulated in individuals with obesity, suggesting a link between its expression levels and obesity-related traits (Mao2020Coding). The gene has also been mentioned in the context of type 1 diabetes (T1D), where its expression is part of complex transcriptional regulatory circuits associated with T1D risk loci, although specific diseases or conditions directly linked to NPIPB9 mutations or expression alterations in T1D are not detailed (Kim2021A). These findings highlight the potential clinical significance of NPIPB9 in various immune-related and metabolic conditions.


## References


[1. (Kim2021A) Seung-Soo Kim, Adam D. Hudgins, Jiping Yang, Yizhou Zhu, Zhidong Tu, Michael G. Rosenfeld, Teresa P. DiLorenzo, and Yousin Suh. A comprehensive integrated post-gwas analysis of type 1 diabetes reveals enhancer-based immune dysregulation. PLOS ONE, 16(9):e0257265, September 2021. URL: http://dx.doi.org/10.1371/journal.pone.0257265, doi:10.1371/journal.pone.0257265. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0257265)

[2. (Li2023Immuneresponse) Lei Li, Xuelian Ma, Ya Cui, Maxime Rotival, Wenyan Chen, Xudong Zou, Ruofan Ding, Yangmei Qin, Qixuan Wang, Lluis Quintana-Murci, and Wei Li. Immune-response 3′utr alternative polyadenylation quantitative trait loci contribute to variation in human complex traits and diseases. Nature Communications, December 2023. URL: http://dx.doi.org/10.1038/s41467-023-44191-1, doi:10.1038/s41467-023-44191-1. This article has 0 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-023-44191-1)

[3. (Mao2020Coding) Ke Mao, Meixian Zhang, Jinshuai Cao, Xiaoyuan Zhao, Liwang Gao, Liwan Fu, Hong Cheng, Chun Yan, Xiaopeng Xu, Xiaofeng Shi, Zhuoyuan Jiang, Bingqing Wang, Yong‐Biao Zhang, and Jie Mi. Coding variants are relevant to the expression of obesity‐related genes for pediatric adiposity. Obesity, 29(1):194–203, December 2020. URL: http://dx.doi.org/10.1002/oby.23046, doi:10.1002/oby.23046. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/oby.23046)

[4. (Kim2024Largescale) Daeun Kim, Jaeseung Song, Nicholas Mancuso, Serghei Mangul, Junghyun Jung, and Wonhee Jang. Large-scale integrative analysis of juvenile idiopathic arthritis for new insight into its pathogenesis. Arthritis Research &amp; Therapy, February 2024. URL: http://dx.doi.org/10.1186/s13075-024-03280-2, doi:10.1186/s13075-024-03280-2. This article has 0 citations.](https://doi.org/10.1186/s13075-024-03280-2)